Author(s):
Alka Singh, Jitendra Bajaj
Email(s):
alkasingh@sistec.ac.in
DOI:
10.52711/0974-4150.2026.00064 
Address:
Alka Singh1*, Jitendra Bajaj2
1Professor, Sagar Institute of Pharmaceutical Technology and Research, Sikandrabad, Near Ratibad, Bhadbada Road, Bhopal, Madhya Pradesh-462044, India.
2Professor and Principal, Sagar Institute of Pharmaceutical Technology and Research, Sikandrabad, Near Ratibad, Bhadbada Road, Bhopal, Madhya Pradesh-462044, India.
*Corresponding Author
Published In:
Volume - 19,
Issue - 5,
Year - 2026
ABSTRACT:
A simple, sensitive, fast, and economical HPLC method was developed and validated for estimation of Amlodipine Antihypertensive Drug in simulated Human plasma. The validated HPLC method was used to quantify the concentration of selected actives in ultrafiltrate. Optimum separation conditions were obtained with Thermo ß-basic C18 (100x 4.6 mm i.d., 5µ) column with mobile phase consisting of 10 mM Monobasic phosphate (pH 3.0) and acetonitrile (ACN) in gradient mode with column oven temperature maintained at around 25° C and elution monitored by a UV detector at 239nm. Protein precipitation was employed to extract the selected analyte form human plasma. The recoveries were more than 90%. The accuracy of samples for six replicate measurements was found within limit. The precision of samples for six replicate measurements was found within limit. The validated method was applied for quantitation of selected analytes in ultrafiltrate from protein binding experiments. The extraction efficiency of AMLO was found to be about 88.52%.
Cite this article:
Alka Singh, Jitendra Bajaj. Development and Validation of a HPLC-UV Method for Antihypertensive Drug Amlodipine in Simulated Human Plasma Application to Protein Binding Studies. Asian Journal of Research in Chemistry. 2026; 19(5):435-1. doi: 10.52711/0974-4150.2026.00064
Cite(Electronic):
Alka Singh, Jitendra Bajaj. Development and Validation of a HPLC-UV Method for Antihypertensive Drug Amlodipine in Simulated Human Plasma Application to Protein Binding Studies. Asian Journal of Research in Chemistry. 2026; 19(5):435-1. doi: 10.52711/0974-4150.2026.00064 Available on: https://www.ajrconline.org/AbstractView.aspx?PID=2026-19-5-5
REFERENCES:
1. Chobanian, A. V.; Bakris, G. L.; Black, H. R.; Cushman, W. C.; Green, L. A.; Izzo, J. L., Jr.; Jones, D. W.; Materson, B. J.; Oparil, S.; Wright, J. T., Jr.; Roccella, E. J.; National Heart, L.; Blood Institute Joint National Committee on Prevention, D. E.; Treatment of High Blood, P.; National High Blood Pressure Education Program Coordinating, C. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003; 289(19): 2560-72.
2. Choi, D.H.; Piao, Y.J.; Choi, E. J.; Choi, J.-S.; Burm, J.P. Effects of Amlodipine on the Pharmacokinetics of Warfarin after Oral and Intravenous Administration of Warfarin in Rats. Biomolecules and Therapeutics. 2011, 19.
3. Kario, K., Okura, A., Hoshide, S. and Mogi, M. The WHO global report 2023 on hypertension warning the emerging hypertension burden in Globe and its treatment strategy. Hypertens. Res. 2024; 47: 1099–1102.
4. Elliott, W. J. Systemic Hypertension. Curr. Probl. Cardiol. 2007; 32: 201–259.
5. Kokubo, Y. and Matsumoto, C. Hypertension is a risk factor for several types of heart disease: review of prospective studies. Adv. Exp. Med. Biol. 2017; 956: 419–426.
6. Wang, J. G., Palmer, B. F., Anderson, V., Sever, P. and K. and Amlodipine in the current management of hypertension. J. Clin. Hypertens. (Greenwich). 2023; 25: 801–807.
7. 21. Moon, J. S. and Won, K. C. Oxidative stress: link between hypertension and diabetes. Korean J. Intern. Med. 2017; 32: 439–441.
8. Kim, H. J. et al. Effects of Valsartan and amlodipine on oxidative stress in type 2 diabetic patients with hypertension: a randomized, multicenter study. Korean J. Intern. Med. 2017; 32: 497–504.
9. Frampton, J. E. and Scott, L. J. Amlodipine/valsartan single-pill combination: a review of its use in the management of hypertension. Am. J. Cardiovasc. Drugs. 2009; 9: 309–330.
10. “Section 11. Cardiovascular Disorders – Chapter 85. Hypertension”. Merck Manual of Geriatrics. July 2005. Archived from the original on 2009-01-23.
11. “Decision aid helps pregnant women with high blood pressure”. NIHR Evidence. 15 February 2023
12. “Hyperaldosteronism”. The Lecturio Medical Concept Library. Retrieved 25 July2021
13. Ahmed M; Alshabrawy A; and Nageh A. UPLC-MS/MS Method for Kinetic Studies and Simultaneous Determination of Amlodipine and Atorvastatin in Bulk, and Their Combined Dosage Form. Anal Chem Ind J. 2016; 16(14): 102.
14. Cryer, M. J., Horani, T. and DiPette, D. J. Diabetes and hypertension: A comparative review of current guidelines. J. Clin. Hypertens. (Greenwich). 2016; 18: 95–100.
15. M; Alshabrawy A; and Nageh A. UPLC-MS/MS Method for Kinetic Studies and Simultaneous Determination of Amlodipine and Atorvastatin in Bulk, and Their Combined Dosage Form. Anal Chem Ind J. 2016; 16(14): 102.
16. Karolina Dańkowska, Miłosz Nesterowicz, Kamil Klaudiusz Lauko, Daria Trocka, Małgorzata Żendzian-Piotrowska, Jerzy Robert Ładny, Anna Zalewska, Marta Żebrowska-Gamdzyk and Mateusz Maciejczyk. In vitro and in silico studies and a systematic literature review of antiglycation properties of amlodipine. Scientific Reports. 2025; 15: 33277.